…
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the cooling experience; and DelCool, a thermal management product. The company also provides flame retardant solutions, including Alexiflam, a flame-retardant treatment for cotton and cellulose-based textiles; AlexiGuard, a flame-retardant emulsion tailored for 100% polyester fabric; and AlexiShield, a water-resistant flame-retardant solution for providing enhanced flame resistance in mattresses. In addition, it offers Nextek, a mPCM technology delivering high thermal stability with robust capsule walls; Vivtek, a single integrated solution combining a strong, versatile capsule wall with a bio-based core; and microencapsulated PCM technologies. It serves furniture, bedding and mattress, defense, performance apparel, building materials, electronics, life science and medical devices, packaging and logistics, personal comfort and safety, and transportation markets. The company is headquartered in Greer, South Carolina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Alexium International Group Ltd is an Australian specialty materials company that develops proprietary flame-retardant and thermal-management treatments for textiles, foam and polymers, serving bedding, apparel and industrial customers. Long-term drivers include regulatory demand for non-halogenated flame retardants, growth in performance textiles and bedding, and scale-up or licensing of technology, which may appeal to investors seeking niche chemical innovation.
Key risks are execution and financing constraints tied to its small scale, competition from larger chemical firms, and regulatory or patent uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -6.29M | -3.93M | -2.76M | -2.95M | -3.36M |
| Net income | -6.29M | -3.93M | -2.76M | -2.95M | -4.14M |
| Selling general administrative | 4.39M | 2.69M | 2.80M | 2.87M | 2.46M |
| Selling and marketing expenses | 0.47M | 0.45M | 0.35M | 0.52M | 0.85M |
| Gross profit | 1.23M | 1.69M | 2.64M | 2.82M | 3.33M |
| Reconciled depreciation | - | 0.55M | 0.81M | 0.66M | 1.05M |
| Ebit | -4.52M | -3.80M | -1.77M | -2.05M | -1.56M |
| Ebitda | -2.71M | -3.25M | -0.96M | -1.38M | -0.51M |
| Depreciation and amortization | 1.81M | 0.55M | 0.81M | 0.66M | 1.05M |
| Operating income | -4.17M | -3.16M | -2.45M | -3.30M | -1.56M |
| Other operating expenses | 8.41M | 7.08M | 8.34M | 0.62M | 10.42M |
| Interest expense | - | 0.13M | 1.62M | 0.91M | 0.78M |
| Tax provision | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 0.04M | 0.03M | 0.19M | 0.00M |
| Net interest income | - | -0.14M | -1.03M | -0.97M | -0.77M |
| Income tax expense | - | - | 0.68M | 1.12M | 0.78M |
| Total revenue | 4.24M | 3.92M | 5.89M | 7.21M | 8.17M |
| Total operating expenses | 5.40M | 4.85M | 5.09M | 5.02M | 5.58M |
| Cost of revenue | 3.01M | 2.23M | 3.25M | 4.39M | 4.85M |
| Total other income expense net | -2.11M | -0.77M | -0.31M | 0.22M | -1.80M |
| Net income from continuing ops | - | -3.93M | -2.76M | -2.95M | -3.36M |
| Net income applicable to common shares | - | -3.93M | -2.76M | -2.95M | -3.36M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 2.34M | 2.88M | 5.23M | 5.38M | 6.42M |
| Intangible assets | 0.08M | 0.08M | 0.76M | 1.70M | 1.57M |
| Other current assets | 0.09M | 0.06M | 0.07M | 0.09M | 0.09M |
| Total liab | 2.68M | 3.28M | 1.93M | 6.36M | 4.85M |
| Total stockholder equity | -0.34M | -0.40M | 3.30M | -0.98M | 1.58M |
| Deferred long term liab | - | - | - | 1.70M | 1.57M |
| Other current liab | - | - | 0.60M | 0.42M | 0.41M |
| Common stock | 80.15M | - | 73.59M | 66.61M | 66.52M |
| Capital stock | - | 73.78M | - | 66.61M | 66.52M |
| Retained earnings | -78.99M | -72.77M | -69.09M | -66.62M | -63.75M |
| Other liab | - | - | - | 0.69M | 0.18M |
| Other assets | - | - | - | 1.71M | 1.59M |
| Cash | 0.22M | 0.66M | 2.05M | 0.51M | 1.03M |
| Total current liabilities | 2.55M | 1.40M | 1.48M | 1.29M | 1.11M |
| Net debt | 1.10M | 1.44M | -1.68M | 4.17M | 2.82M |
| Short term debt | 1.19M | - | 0.37M | 0.30M | 0.30M |
| Short long term debt | - | 0.48M | - | 0.16M | 0.18M |
| Short long term debt total | 1.32M | - | 0.37M | 4.69M | 3.85M |
| Other stockholder equity | - | - | - | -1.60M | -1.28M |
| Property plant equipment | - | - | - | 1.20M | 1.54M |
| Total current assets | 2.19M | 2.18M | 3.58M | 2.47M | 3.30M |
| Long term investments | - | 0.02M | - | 0.02M | 0.02M |
| Net tangible assets | - | - | - | -0.98M | 1.58M |
| Net receivables | 0.39M | 0.35M | 0.90M | 1.05M | 0.58M |
| Long term debt | - | 1.62M | - | 3.79M | 2.82M |
| Inventory | 1.49M | 1.05M | 0.56M | 0.82M | 1.60M |
| Accounts payable | 1.36M | 0.41M | 0.52M | 0.57M | 0.41M |
| Accumulated other comprehensive income | -1.50M | - | -1.21M | -0.97M | -1.20M |
| Non currrent assets other | 0.02M | - | 0.00M | - | 0.02M |
| Non current assets total | 0.15M | 0.70M | 1.65M | 2.91M | 3.13M |
| Capital lease obligations | - | 0.44M | - | 0.74M | 0.86M |
| Long term debt total | - | - | - | 4.39M | 3.55M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -0.22M | -0.16M | -0.39M | -0.35M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -0.01M | -0.22M | -0.16M | -0.39M | -0.35M |
| Net borrowings | - | 1.58M | 0.23M | 1.00M | 0.14M |
| Total cash from financing activities | 2.85M | 1.42M | 2.91M | 1.00M | 0.07M |
| Change to operating activities | - | - | - | 0.02M | 0.20M |
| Net income | -6.29M | -3.93M | -2.76M | -2.95M | -4.14M |
| Change in cash | -0.48M | -1.39M | 1.54M | -0.51M | -1.91M |
| Begin period cash flow | 0.70M | 2.05M | 0.51M | 1.03M | 2.93M |
| End period cash flow | 0.22M | 0.66M | 2.05M | 0.51M | 1.03M |
| Total cash from operating activities | -3.33M | -2.58M | -1.19M | -1.10M | -3.09M |
| Issuance of capital stock | - | - | 2.98M | - | - |
| Depreciation | 1.81M | - | - | 0.36M | 1.05M |
| Other cashflows from investing activities | - | -0.21M | -0.16M | -0.37M | -0.30M |
| Change to inventory | -0.10M | - | - | 0.77M | -0.38M |
| Change to account receivables | 0.03M | - | - | -0.31M | -0.26M |
| Sale purchase of stock | - | -0.01M | -0.17M | -0.00M | -0.00M |
| Other cashflows from financing activities | 0.03M | -0.16M | -0.14M | 6.68M | 0.19M |
| Change to netincome | - | - | - | 0.70M | 1.18M |
| Capital expenditures | 0.00M | 0.22M | 0.16M | 0.39M | 0.35M |
| Change in working capital | 0.54M | 0.04M | 0.03M | 0.01M | 0.00M |
| Other non cash items | 0.61M | -2.58M | -1.19M | - | 3.09M |
| Free cash flow | -3.33M | -2.80M | -1.35M | -1.49M | -3.44M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AJX Alexium International Group Ltd |
- -% |
0.01 | - | 6.00 | 3.74 | 3.54 | 2.88 | -8.46 |
| ORI Orica Ltd |
-0.42 1.83% |
22.50 | 44.94 | 16.18 | 1.30 | 2.74 | 1.57 | 10.83 |
| DNL Dyno Nobel Ltd |
-0.11 2.80% |
3.82 | 28.07 | 21.10 | 1.76 | 1.65 | 2.17 | 10.94 |
| DGL DGL Group Ltd |
0.02 8.33% |
0.26 | - | 13.37 | 0.15 | 0.23 | 0.52 | 34.58 |
| ADO Anteotech Ltd |
-0.00 11.11% |
0.02 | - | 10.50 | 125.69 | 4.15 | 85.38 | -4.53 |
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the cooling experience; and DelCool, a thermal management product. The company also provides flame retardant solutions, including Alexiflam, a flame-retardant treatment for cotton and cellulose-based textiles; AlexiGuard, a flame-retardant emulsion tailored for 100% polyester fabric; and AlexiShield, a water-resistant flame-retardant solution for providing enhanced flame resistance in mattresses. In addition, it offers Nextek, a mPCM technology delivering high thermal stability with robust capsule walls; Vivtek, a single integrated solution combining a strong, versatile capsule wall with a bio-based core; and microencapsulated PCM technologies. It serves furniture, bedding and mattress, defense, performance apparel, building materials, electronics, life science and medical devices, packaging and logistics, personal comfort and safety, and transportation markets. The company is headquartered in Greer, South Carolina.
350 West Phillips Road, Greer, SC, United States, 29650
803-715-3641
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason Lewis | Chief Financial Officer | NA |
| Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Exec. Director | NA |
| Mr. William Timothy Blackburn | CEO & Managing Director | NA |
| Mr. Mark Wise | VP of Investor Relations & Corp. Communications | NA |
| Ms. Maja Aleksandra McGuire | Gen. Counsel | NA |
| Mr. Scott Hunter | VP of Sales | NA |
| Ms. Jessica Hutchison | VP of HR | NA |
| Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Company Sec. | 1964 |
| Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Executive Director | NA |
| Dr. Robert Brookins B.A., B.Sc., Ph.D. | CTO & Executive Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.